GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
59.65
-2.15 (-3.48%)
At close: May 15, 2026, 4:00 PM EDT
59.00
-0.65 (-1.09%)
Pre-market: May 18, 2026, 4:01 AM EDT
GRAIL Revenue
GRAIL had revenue of $40.79M in the quarter ending March 31, 2026, with 28.11% growth. This brings the company's revenue in the last twelve months to $156.12M, up 19.44% year-over-year. In the year 2025, GRAIL had annual revenue of $147.17M with 17.18% growth.
Revenue (ttm)
$156.12M
Revenue Growth
+19.44%
P/S Ratio
16.40
Revenue / Employee
$171,560
Employees
910
Market Cap
2.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 147.17M | 21.58M | 17.18% |
| Dec 31, 2024 | 125.60M | 32.49M | 34.90% |
| Dec 31, 2023 | 93.11M | 37.56M | 67.61% |
| Jan 1, 2023 | 55.55M | 40.94M | 280.17% |
| Jan 2, 2022 | 14.61M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Charles River Laboratories International | 4.03B |
| RadNet | 2.14B |
| Qiagen | 2.10B |
| Sotera Health Company | 1.19B |
| NeoGenomics | 745.97M |
| Veracyte | 541.74M |
| GeneDx Holdings | 442.68M |
| CareDx | 412.82M |
GRAL News
- 5 days ago - GRAIL Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 11 days ago - Grail price target lowered to $70 from $82 at Baird - TheFly
- 11 days ago - Grail price target raised to $56 from $54 at Piper Sandler - TheFly
- 11 days ago - Grail price target raised to $69 from $65 at TD Cowen - TheFly
- 11 days ago - Zaya Younan Unveils the Scientific Holy Grail of Cigar Smoking - GlobeNewsWire
- 12 days ago - Grail reports Q1 EPS ($2.29), consensus ($1.96) - TheFly
- 12 days ago - GRAIL Earnings Call Transcript: Q1 2026 - Transcripts
- 12 days ago - GRAIL Reports First Quarter 2026 Financial Results - PRNewsWire